Physician profile
Devinder Singh
NPI 1568646321
$406,888.55
in general payments reported to CMS, 2019-2025
29 companies · $126K in 2025
The $126K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2021: $10K · 2022: $3,156 · 2023: $83K · 2024: $112K · 2025: $126K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $192K · Consulting Fee: $93K · Travel and Lodging: $27K · Food and Beverage: $10K · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $191,550.00 |
| Consulting Fee | $92,687.50 |
| Travel and Lodging | $26,563.63 |
| Food and Beverage | $10,083.93 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $232,233.28 | 2024-2025 | Prevena, V.A.C. Veraflo, Prevena Restor Bellaform |
| Kci USA, INC. | $147,566.99 | 2019-2023 | Prevena, V.A.C. Veraflo, Prevena Restor Bellaform |
| W. L. Gore & Associates, INC. | $15,605.10 | 2019-2024 | Gore Enform Preperitoneal Biomaterial |
| Axogen | $2,133.40 | 2021-2023 | Avance Nerve Graft |
| Abbvie INC. | $2,079.99 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Motiva USA, LLC | $1,940.35 | 2025 | |
| Allergan, INC. | $1,410.83 | 2021-2022 | |
| Davol INC. | $584.71 | 2022-2025 | Phasix Mesh |
| Musculoskeletal Transplant Foundation INC. | $444.28 | 2025 | |
| Poriferous LLC | $317.51 | 2022 | |
| Becton, Dickinson and Company | $309.15 | 2025 | Galaflex, Phasix Mesh |
| Innovation Technologies INC | $269.92 | 2025 | Irrisept |
| Somavac Medical Solutions, INC. | $241.93 | 2025 | Somavac 100 Sustained Vacuum System |
| Mimedx Group, INC. | $196.16 | 2024 | |
| Stryker Corporation | $171.85 | 2023 | Spy-Phi System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $170.07 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Sientra, INC. | $158.87 | 2022 | |
| Polynovo North America LLC | $152.42 | 2025 | Novosorb Btm |
| Acera Surgical, INC. | $151.40 | 2023 | Restrata Wound Matrix |
| Galderma Laboratories, L.P. | $144.47 | 2024 | |
| Integra Lifesciences Corporation | $139.89 | 2023 | Durasorb Monofilament Mesh |
| Solta Medical, A Division of Bausch Health US, LLC | $124.12 | 2021 | |
| Biotissue Holdings INC. | $118.75 | 2024 | |
| Baxter Healthcare | $62.36 | 2019-2024 | |
| Smith+Nephew, INC. | $51.28 | 2025 | Collagenase Santyl |
| Coopersurgical, INC. | $38.40 | 2021-2025 | Onetrac Lx |
| Abbott Laboratories | $25.84 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Eisai INC. | $22.99 | 2024 | |
| Novo Nordisk INC | $22.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devinder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.